Zhimeng Wu

26PUBLICATIONS
18CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesBiomaterialsProcess control and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jan 31, 2026
A Dually Nanobody-Engineered Milk-Derived Extracellular Vesicle Nanomedicine Targeting Tumour-Associated Macrophages and Cancer Cells for Cancer Therapy.

Zhiang Liu, Ying Chen, Yulin Cao

|Jan 07, 2026
Chemoenzymatic Synthesis of Nanobody-Peptide Conjugates Capable of Harnessing HBV Vaccine-Induced Antibodies for Cancer Immunotherapy.

Haofei Hong, Zijiang Zhang, Zheng Wang

|Dec 19, 2025
Integrin-specific binding macrocyclic RGD peptides functionalized with dinitrophenol as multivalent antibody-recruiting molecules to enhance cytotoxicity in cancer immunotherapy.

Xiaozhong Cheng, Chenrui Hu, Wanru Gao

|Oct 30, 2025
Chemoenzymatic Synthesis of Rhamnolipid-Modified Exendin-4: A Dual Approach for Long-Acting Glycemic Control through Endogenous Antibody Recruitment and Albumin Interaction.

Shijie Dai, Haiyan Liu, Baojing Mi

|Sep 02, 2025
Repurposing vaccine-induced anti-HBV antibodies for endogenous immunotherapy against EGFR-positive tumors.

Zijiang Zhang, Yanchun Li, Haofei Hong

|Aug 05, 2025
Engineered Nanobody Chimeras Recruits Anti-HBV Antibodies for Target Cancer Immunotherapy.

Zijiang Zhang, Yanchun Li, Zheng Wang

Pageof 5

Frequent Collaborators

5 joint publications

Zhifang Zhou

3 joint publications

Liang Gong

3 joint publications

Jie Shi

2 joint publications

Haofei Hong